Company / Financials
CLOVER HEALTH INVESTMENTS, CORP. /DE Financials
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$1.9B
FY2025 · +40.3% YoY
Net Income
-$85.5M
FY2025 · -98.9% YoY
Profit Margin
-4.5%
FY2025 · net income / revenue
ROE
-27.7%
FY2025 · return on equity
Total Assets
$541.0M
FY2025
Total Debt
-
FY2025
Equity
$308.7M
FY2025
ROA
-15.8%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$1.9B+40.3% YoYNet Income HistoryProfit after all expenses and taxes-$85.5M-98.9% YoYGross Profit HistoryRevenue minus cost of goods sold$257.3MOperating Income HistoryProfit from core business operations before interest and taxes-$85.5M-87.0% YoYSG&A Expense HistorySelling, general, and administrative expenses$214.3M+21.4% YoYInterest Expense HistoryCost of borrowing and debt obligations$7.0KIncome Tax HistoryTotal income tax expense$0EPS (Basic) HistoryBasic earnings per share-$0.44EPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$0.44Shares Outstanding HistoryWeighted average diluted shares outstanding482.2M-1.6% YoY